{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:48:32Z","timestamp":1788364112799,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03116-2","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T05:48:49Z","timestamp":1748152129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ultrasound guided transabdominal botulinum toxin injection for refractory overactive bladder treatment"],"prefix":"10.1038","volume":"15","author":[{"given":"Junhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"3116_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/nau.24171","volume":"39","author":"S Malde","year":"2020","unstructured":"Malde, S., Kelly, S., Saad, S. & Sahai, A. Case-finding tools for the diagnosis of OAB in women: A narrative review. Neurourol. Urodyn. 39, 13\u201324 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"3116_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11934-019-0893-5","volume":"20","author":"A El-Zawahry","year":"2019","unstructured":"El-Zawahry, A. Combination pharmacotherapy for treatment of overactive bladder (OAB). Curr. Urol. Rep. 20, 33 (2019).","journal-title":"Curr. Urol. Rep."},{"key":"3116_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.juro.2018.09.043","volume":"201","author":"S De Wachter","year":"2019","unstructured":"De Wachter, S. et al. Six-month results of selective bladder denervation in women with refractory overactive bladder. J. Urol. 201, 573\u2013580 (2019).","journal-title":"J. Urol."},{"key":"3116_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.JAA.0000476217.57808.c4","volume":"29","author":"S Harris","year":"2016","unstructured":"Harris, S. & Rizzolo, D. Botulinum toxin as a treatment for refractory overactive bladder. JAAPA 29, 1\u20134 (2016).","journal-title":"JAAPA"},{"key":"3116_CR5","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/nau.24474","volume":"39","author":"SR Kraus","year":"2020","unstructured":"Kraus, S. R. et al. Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or OnabotulinumtoxinA in the united States. Neurourol. Urodyn. 39, 2206\u20132222 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"3116_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/tcmj.tcmj_313_21","volume":"35","author":"YH Jiang","year":"2023","unstructured":"Jiang, Y. H., Jhang, J. F. & Kuo, H. C. The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis. Tzu Chi Med. J. 35, 31\u201337 (2023).","journal-title":"Tzu Chi Med. J."},{"key":"3116_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2016.10.026","volume":"100","author":"H L\u00f3pez Ramos","year":"2017","unstructured":"L\u00f3pez Ramos, H., Torres Castellanos, L., Ponce Esparza, I., Jaramillo, A. & Rodr\u00edguez, A. Moreno Bencardino, C. Management of overactive bladder with OnabotulinumtoxinA: systematic review and Meta-analysis. Urology 100, 53\u201358 (2017).","journal-title":"Urology"},{"key":"3116_CR8","doi-asserted-by":"crossref","unstructured":"Li, J., Liu, W., Tang, C., Pan, H. & Song, C. Clinical efficacy and safety analysis of type A botulinum toxin in the treatment of adolescents with refractory overactive bladder. Med. (Baltim). 103, e38803. (2024).","DOI":"10.1097\/MD.0000000000038803"},{"key":"3116_CR9","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/nau.23551","volume":"37","author":"P Abrams","year":"2018","unstructured":"Abrams, P. et al. 6th international consultation on incontinence. Recommendations of the international scientific committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE. Neurourol. Urodyn. 37, 2271\u20132272 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"3116_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/nau.23447","volume":"37","author":"V Bjelic-Radisic","year":"2018","unstructured":"Bjelic-Radisic, V. et al. Psychometric properties and validation of two global impression questionnaires (PGI-S, PGI-I) for stress incontinence in a German-speaking female population. Neurourol. Urodyn. 37, 1365\u20131371 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"3116_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/toxins15020166","volume":"15","author":"JC Hu","year":"2023","unstructured":"Hu, J. C., Hsu, L. N., Lee, W. C., Chuang, Y. C. & Wang, H. J. Role of urological botulinum Toxin-A injection for overactive bladder and voiding dysfunction in patients with Parkinson\u2019s disease or Post-Stroke. Toxins 15, 166 (2023).","journal-title":"Toxins"},{"key":"3116_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00345-021-03850-y","volume":"40","author":"G De Sallmard","year":"2022","unstructured":"De Sallmard, G. et al. Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter. World J. Urol. 40, 489\u2013495 (2022).","journal-title":"World J. Urol."},{"key":"3116_CR13","doi-asserted-by":"publisher","first-page":"32e1","DOI":"10.1016\/j.jpurol.2018.08.007","volume":"15","author":"J Ingham","year":"2019","unstructured":"Ingham, J., Angotti, R., Lewis, M. & Goyal, A. Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium-term outcomes. J. Pediatr. Urol. 15, 32e1\u201332e5 (2019).","journal-title":"J. Pediatr. Urol."},{"key":"3116_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/nau.25107","volume":"42","author":"AM DiCarlo-Meacham","year":"2023","unstructured":"DiCarlo-Meacham, A. M. et al. Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder. Neurourol. Urodyn. 42, 366\u2013374 (2023).","journal-title":"Neurourol. Urodyn."},{"key":"3116_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/nau.23052","volume":"36","author":"MA Avallone","year":"2017","unstructured":"Avallone, M. A., Sack, B. S., El-Arabi, A., Guralnick, M. L. & O\u2019Connor, R. C. Less is more-A pilot study evaluating one to three intradetrusor sites for injection of OnabotulinumtoxinA for neurogenic and idiopathic detrusor overactivity. Neurourol. Urodyn. 36, 1104\u20131107 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"3116_CR16","doi-asserted-by":"crossref","unstructured":"Sun, L. C. et al. Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials. BioMed Res. Int. 2019, 8329306. (2019).","DOI":"10.1155\/2019\/8329306"},{"key":"3116_CR17","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3390\/toxins7083045","volume":"7","author":"A Santamato","year":"2015","unstructured":"Santamato, A. et al. Ultrasound-Guided injection of botulinum toxin type A for piriformis muscle syndrome: A case report and review of the literature. Toxins 7, 3045\u20133056 (2015).","journal-title":"Toxins"},{"key":"3116_CR18","doi-asserted-by":"crossref","unstructured":"Jiang, Y. H. et al. Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System LesionsToxins. Mar 01;16(3). (2024).","DOI":"10.3390\/toxins16030123"},{"key":"3116_CR19","first-page":"1","volume":"14","author":"M Barba","year":"2022","unstructured":"Barba, M. & Lazar, T. Learning curve of botulinum toxin bladder injection for the treatment of refractory overactive bladderInternational. J. Women\u2019s Health. 14, 1\u20137 (2022).","journal-title":"J. Women\u2019s Health"},{"issue":"1","key":"3116_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10790268.2019.1603490","volume":"01","author":"AM Kajbafzadeh","year":"2021","unstructured":"Kajbafzadeh, A. M., Ahmadi, H. & Laleh Montaser-Kouhsari. Intravesical electromotive administration of botulinum toxin type A in improving the bladder and bowel functions: evidence for novel mechanism of action. J. Spinal Cord Med. 01 (1), 89\u201395 (2021).","journal-title":"J. Spinal Cord Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03116-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T05:48:52Z","timestamp":1748152132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03116-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03116-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the Declaration of Helsinki.This study was conducted with approval from the Ethics Committee of Hangzhou Third People\u2019s Hospital (Y-KL2025025). Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"18162"}}